Sculptor Capital LP Alvotech Transaction History
Sculptor Capital LP
- $2.29 Billion
- Q1 2025
A detailed history of Sculptor Capital LP transactions in Alvotech stock. As of the latest transaction made, Sculptor Capital LP holds 40,811 shares of ALVO stock, worth $399,131. This represents 0.02% of its overall portfolio holdings.
Number of Shares
40,811
Previous 606,170
93.27%
Holding current value
$399,131
Previous $8 Million
95.08%
% of portfolio
0.02%
Previous 0.23%
Shares
6 transactions
Others Institutions Holding ALVO
# of Institutions
50Shares Held
15.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.19MShares$41 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$26.5 Million20.4% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.87MShares$18.3 Million0.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.4MShares$13.7 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$12.9 Million6.46% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.43B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...